CORBION NV (CRBN.AS) Stock Fundamental Analysis
Europe - Euronext Amsterdam - AMS:CRBN - NL0010583399 - Common Stock
19.11 EUR
-0.16 (-0.83%)
We assign a fundamental rating of 5 out of 10 to CRBN. CRBN was compared to 74 industry peers in the Chemicals industry. Both the profitability and the financial health of CRBN get a neutral evaluation. Nothing too spectacular is happening here. CRBN is valued quite cheap, but it does not seem to be growing. This makes CRBN very considerable for value investing!
1. Profitability
1.1 Basic Checks
CRBN had positive earnings in the past year.
In the past year CRBN had a positive cash flow from operations.
In the past 5 years CRBN has always been profitable.
CRBN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 4.55%, CRBN is doing good in the industry, outperforming 68.92% of the companies in the same industry.
With a decent Return On Equity value of 9.12%, CRBN is doing good in the industry, outperforming 67.57% of the companies in the same industry.
CRBN has a Return On Invested Capital of 9.19%. This is in the better half of the industry: CRBN outperforms 75.68% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRBN is in line with the industry average of 6.87%.
The 3 year average ROIC (6.62%) for CRBN is below the current ROIC(9.19%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.55% | ||
| ROE | 9.12% | ||
| ROIC | 9.19% |
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
1.3 Margins
The Profit Margin of CRBN (5.11%) is better than 64.86% of its industry peers.
CRBN's Profit Margin has improved in the last couple of years.
CRBN has a Operating Margin of 8.68%. This is in the better half of the industry: CRBN outperforms 64.86% of its industry peers.
In the last couple of years the Operating Margin of CRBN has declined.
CRBN has a Gross Margin of 26.10%. This is in the lower half of the industry: CRBN underperforms 60.81% of its industry peers.
CRBN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.68% | ||
| PM (TTM) | 5.11% | ||
| GM | 26.1% |
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
2. Health
2.1 Basic Checks
CRBN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CRBN has less shares outstanding than it did 1 year ago.
CRBN has less shares outstanding than it did 5 years ago.
CRBN has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.78 indicates that CRBN is not a great score, but indicates only limited risk for bankruptcy at the moment.
CRBN has a better Altman-Z score (2.78) than 64.86% of its industry peers.
The Debt to FCF ratio of CRBN is 4.95, which is a neutral value as it means it would take CRBN, 4.95 years of fcf income to pay off all of its debts.
CRBN has a better Debt to FCF ratio (4.95) than 74.32% of its industry peers.
A Debt/Equity ratio of 0.39 indicates that CRBN is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.39, CRBN perfoms like the industry average, outperforming 56.76% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 4.95 | ||
| Altman-Z | 2.78 |
ROIC/WACC1.44
WACC6.37%
2.3 Liquidity
A Current Ratio of 1.21 indicates that CRBN should not have too much problems paying its short term obligations.
CRBN's Current ratio of 1.21 is on the low side compared to the rest of the industry. CRBN is outperformed by 79.73% of its industry peers.
A Quick Ratio of 0.60 indicates that CRBN may have some problems paying its short term obligations.
CRBN has a worse Quick ratio (0.60) than 87.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.21 | ||
| Quick Ratio | 0.6 |
3. Growth
3.1 Past
The earnings per share for CRBN have decreased strongly by -68.99% in the last year.
Measured over the past years, CRBN shows a very strong growth in Earnings Per Share. The EPS has been growing by 49.47% on average per year.
The Revenue has been growing slightly by 2.95% in the past year.
CRBN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.70% yearly.
EPS 1Y (TTM)-68.99%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%
3.2 Future
CRBN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.24% yearly.
The Revenue is expected to decrease by -1.71% on average over the next years.
EPS Next Y36.6%
EPS Next 2Y21.96%
EPS Next 3Y18.01%
EPS Next 5Y15.24%
Revenue Next Year-1.8%
Revenue Next 2Y0.45%
Revenue Next 3Y1.67%
Revenue Next 5Y-1.71%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CRBN is valuated rather expensively with a Price/Earnings ratio of 17.06.
72.97% of the companies in the same industry are more expensive than CRBN, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CRBN to the average of the S&P500 Index (26.31), we can say CRBN is valued slightly cheaper.
The Price/Forward Earnings ratio is 12.76, which indicates a correct valuation of CRBN.
70.27% of the companies in the same industry are more expensive than CRBN, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CRBN to the average of the S&P500 Index (36.56), we can say CRBN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.06 | ||
| Fwd PE | 12.76 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CRBN is valued a bit cheaper than 64.86% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRBN indicates a rather cheap valuation: CRBN is cheaper than 91.89% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.15 | ||
| EV/EBITDA | 7.99 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CRBN may justify a higher PE ratio.
A more expensive valuation may be justified as CRBN's earnings are expected to grow with 18.01% in the coming years.
PEG (NY)0.47
PEG (5Y)0.34
EPS Next 2Y21.96%
EPS Next 3Y18.01%
5. Dividend
5.1 Amount
CRBN has a Yearly Dividend Yield of 3.24%.
Compared to an average industry Dividend Yield of 3.13, CRBN pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.32, CRBN pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.24% |
5.2 History
The dividend of CRBN has a limited annual growth rate of 5.02%.
Dividend Growth(5Y)5.02%
Div Incr Years1
Div Non Decr Years5
5.3 Sustainability
56.19% of the earnings are spent on dividend by CRBN. This is a bit on the high side, but may be sustainable.
CRBN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP56.19%
EPS Next 2Y21.96%
EPS Next 3Y18.01%
AMS:CRBN (12/1/2025, 1:20:55 PM)
19.11
-0.16 (-0.83%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners91.06%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap1.11B
Revenue(TTM)1.30B
Net Income(TTM)66.20M
Analysts77.14
Price Target23.33 (22.08%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.24% |
Yearly Dividend0.71
Dividend Growth(5Y)5.02%
DP56.19%
Div Incr Years1
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.33%
PT rev (3m)-0.22%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.41%
EPS NY rev (3m)-2.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.83%
Revenue NY rev (3m)-1.06%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.06 | ||
| Fwd PE | 12.76 | ||
| P/S | 0.86 | ||
| P/FCF | 11.15 | ||
| P/OCF | 6.61 | ||
| P/B | 1.53 | ||
| P/tB | 1.76 | ||
| EV/EBITDA | 7.99 |
EPS(TTM)1.12
EY5.86%
EPS(NY)1.5
Fwd EY7.83%
FCF(TTM)1.71
FCFY8.97%
OCF(TTM)2.89
OCFY15.14%
SpS22.26
BVpS12.47
TBVpS10.88
PEG (NY)0.47
PEG (5Y)0.34
Graham Number17.72
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.55% | ||
| ROE | 9.12% | ||
| ROCE | 10.92% | ||
| ROIC | 9.19% | ||
| ROICexc | 9.57% | ||
| ROICexgc | 10.55% | ||
| OM | 8.68% | ||
| PM (TTM) | 5.11% | ||
| GM | 26.1% | ||
| FCFM | 7.7% |
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
ROICexc(3y)7.16%
ROICexc(5y)7.83%
ROICexgc(3y)8.31%
ROICexgc(5y)9.44%
ROCE(3y)7.87%
ROCE(5y)8.47%
ROICexgc growth 3Y0.82%
ROICexgc growth 5Y-11.84%
ROICexc growth 3Y3.78%
ROICexc growth 5Y-8.06%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
F-Score6
Asset Turnover0.89
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 4.95 | ||
| Debt/EBITDA | 1.43 | ||
| Cap/Depr | 81.01% | ||
| Cap/Sales | 5.3% | ||
| Interest Coverage | 7.03 | ||
| Cash Conversion | 85.4% | ||
| Profit Quality | 150.76% | ||
| Current Ratio | 1.21 | ||
| Quick Ratio | 0.6 | ||
| Altman-Z | 2.78 |
F-Score6
WACC6.37%
ROIC/WACC1.44
Cap/Depr(3y)194.04%
Cap/Depr(5y)192.31%
Cap/Sales(3y)11.51%
Cap/Sales(5y)11.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.99%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
EPS Next Y36.6%
EPS Next 2Y21.96%
EPS Next 3Y18.01%
EPS Next 5Y15.24%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%
Revenue Next Year-1.8%
Revenue Next 2Y0.45%
Revenue Next 3Y1.67%
Revenue Next 5Y-1.71%
EBIT growth 1Y54.53%
EBIT growth 3Y8.15%
EBIT growth 5Y1.31%
EBIT Next Year132.41%
EBIT Next 3Y36.9%
EBIT Next 5Y26.73%
FCF growth 1Y171.85%
FCF growth 3YN/A
FCF growth 5Y21.2%
OCF growth 1Y118.83%
OCF growth 3Y101.81%
OCF growth 5Y9.98%
CORBION NV / CRBN.AS FAQ
What is the fundamental rating for CRBN stock?
ChartMill assigns a fundamental rating of 5 / 10 to CRBN.AS.
Can you provide the valuation status for CORBION NV?
ChartMill assigns a valuation rating of 7 / 10 to CORBION NV (CRBN.AS). This can be considered as Undervalued.
What is the profitability of CRBN stock?
CORBION NV (CRBN.AS) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for CRBN stock?
The Price/Earnings (PE) ratio for CORBION NV (CRBN.AS) is 17.06 and the Price/Book (PB) ratio is 1.53.
Can you provide the dividend sustainability for CRBN stock?
The dividend rating of CORBION NV (CRBN.AS) is 6 / 10 and the dividend payout ratio is 56.19%.